Search Page

1

Cite

Share

Turning Discoveries into Treatments: Immunology in Africa.

Osier FHA, Mwandumba HC, Gray CM. Osier FHA, et al. Trends Immunol. 2020 Dec;41(12):1051-1053. doi: 10.1016/j.it.2020.10.007. Epub 2020 Nov 4. Trends Immunol. 2020. PMID: 33160840 Free PMC article. Review.

Cite

Share

2

Cite

Share

Serological Profiling for Malaria Surveillance Using a Standard ELISA Protocol.

Murungi LM, Kimathi RK, Tuju J, Kamuyu G, Osier FHA. Murungi LM, et al. Among authors: osier fha. Methods Mol Biol. 2019;2013:83-90. doi: 10.1007/978-1-4939-9550-9_6. Methods Mol Biol. 2019. PMID: 31267495

Cite

Share

3

Cite

Share

Vaccine candidate discovery for the next generation of malaria vaccines.

Tuju J, Kamuyu G, Murungi LM, Osier FHA. Tuju J, et al. Among authors: osier fha. Immunology. 2017 Oct;152(2):195-206. doi: 10.1111/imm.12780. Epub 2017 Jul 24. Immunology. 2017. PMID: 28646586 Free PMC article. Review.

Cite

Share

4

Cite

Share

Antibody responses to merozoite antigens after natural Plasmodium falciparum infection: kinetics and longevity in absence of re-exposure.

Yman V, White MT, Asghar M, Sundling C, Sondén K, Draper SJ, Osier FHA, Färnert A. Yman V, et al. Among authors: osier fha. BMC Med. 2019 Jan 30;17(1):22. doi: 10.1186/s12916-019-1255-3. BMC Med. 2019. PMID: 30696449 Free PMC article.

Cite

Share

5

Cite

Share

Plasmodium falciparum Merozoite Associated Armadillo Protein (PfMAAP) Is Apically Localized in Free Merozoites and Antibodies Are Associated With Reduced Risk of Malaria.

Aniweh Y, Nyarko PB, Charles-Chess E, Ansah F, Osier FHA, Quansah E, Thiam LG, Kamuyu G, Marsh K, Conway DJ, Tetteh KKA, Awandare GA. Aniweh Y, et al. Among authors: osier fha. Front Immunol. 2020 Apr 7;11:505. doi: 10.3389/fimmu.2020.00505. eCollection 2020. Front Immunol. 2020. PMID: 32318061 Free PMC article.

Cite

Share

6

Cite

Share

Changes in Malaria Epidemiology in Africa and New Challenges for Elimination.

Nkumama IN, O'Meara WP, Osier FHA. Nkumama IN, et al. Among authors: osier fha. Trends Parasitol. 2017 Feb;33(2):128-140. doi: 10.1016/j.pt.2016.11.006. Epub 2016 Dec 6. Trends Parasitol. 2017. PMID: 27939610 Free PMC article. Review.

Cite

Share

7

Cite

Share

KILchip v1.0: A Novel Plasmodium falciparum Merozoite Protein Microarray to Facilitate Malaria Vaccine Candidate Prioritization.

Kamuyu G, Tuju J, Kimathi R, Mwai K, Mburu J, Kibinge N, Chong Kwan M, Hawkings S, Yaa R, Chepsat E, Njunge JM, Chege T, Guleid F, Rosenkranz M, Kariuki CK, Frank R, Kinyanjui SM, Murungi LM, Bejon P, Färnert A, Tetteh KKA, Beeson JG, Conway DJ, Marsh K, Rayner JC, Osier FHA. Kamuyu G, et al. Among authors: osier fha. Front Immunol. 2018 Dec 11;9:2866. doi: 10.3389/fimmu.2018.02866. eCollection 2018. Front Immunol. 2018. PMID: 30619257 Free PMC article.

Cite

Share

8

Cite

Share

Recent insights into humoral and cellular immune responses against malaria.

Beeson JG, Osier FH, Engwerda CR. Beeson JG, et al. Trends Parasitol. 2008 Dec;24(12):578-84. doi: 10.1016/j.pt.2008.08.008. Epub 2008 Oct 8. Trends Parasitol. 2008. PMID: 18848497 Review.

Cite

Share

9

Cite

Share

Targets and Mechanisms Associated with Protection from Severe Plasmodium falciparum Malaria in Kenyan Children.

Murungi LM, Sondén K, Llewellyn D, Rono J, Guleid F, Williams AR, Ogada E, Thairu A, Färnert A, Marsh K, Draper SJ, Osier FHA. Murungi LM, et al. Among authors: osier fha. Infect Immun. 2016 Mar 24;84(4):950-963. doi: 10.1128/IAI.01120-15. Print 2016 Apr. Infect Immun. 2016. PMID: 26787721 Free PMC article.

Cite

Share

10

Cite

Share

Cord blood IgG and the risk of severe Plasmodium falciparum malaria in the first year of life.

Murungi LM, Sondén K, Odera D, Oduor LB, Guleid F, Nkumama IN, Otiende M, Kangoye DT, Fegan G, Färnert A, Marsh K, Osier FH. Murungi LM, et al. Int J Parasitol. 2017 Feb;47(2-3):153-162. doi: 10.1016/j.ijpara.2016.09.005. Epub 2016 Nov 24. Int J Parasitol. 2017. PMID: 27890694 Free PMC article.

Cite

Share